Popat, S., Ramalingam, S., Kim, T. M., Yang, J., Riely, G., Mekhail, T., Nguyen, D., Garcia Campelo, M. R., Felip, E., Spira, A., Piotrowska, Z., Bazhenova, L., Vincent, S., Jin, S., Griffin, C., Diderichsen, P., Gupta, N., Bunn, V., Lin, J., Lin, H., Churchill, E., Mehta, M., Zhou, C., & Jänne, P. (n.d.). mobocertinib (TAK-788) in epidermal growth factor receptor gene (EGFR) exon 20 insertion mutation-positive (EGFRex20ins+) metastatic non-small cell lung cancer (mNSCLC): results from the platinum-pretreated patients (PPP) cohort of a phase 1/2 study. Lung cancer, 165, S30–S31. http://access.bl.uk/ark:/81055/vdc_100150602449.0x00004f